Madison Avenue Partners, LP - 25 Mar 2025 SCHEDULE 13G Report for Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Filing Manager: Madison Avenue Partners, LP
Reporting Manager: Madison Avenue International LP
Security: Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock")
Symbol: SAGE
Shares outstanding: 61.5M shares
Disclosed Ownership: 4.92M shares
Ownership: 8%
Form type: SCHEDULE 13G
Date filed: 01 Apr 2025, 17:35
Date of event: 25 Mar 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (6)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Madison Avenue International LP	8%	4.92M	4.92M	/s/ Eli Samaha	Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
Madison Avenue Partners, LP	8%	4.92M	4.92M	/s/ Eli Samaha	Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
EMAI Management, LLC	8%	4.92M	4.92M	/s/ Eli Samaha	Eli Samaha, as Managing Member
Madison Avenue GP, LLC	8%	4.92M	4.92M	/s/ Eli Samaha	Eli Samaha, as Manager
Caraway Jackson Investments LLC	8%	4.92M	4.92M	/s/ Eli Samaha	Eli Samaha, as Member
Eli Samaha	8%	4.92M	4.92M	/s/ Eli Samaha	Eli Samaha